The aim of�Gene Therapy and Regulation�is to meet the demand for an international interdisciplinary journal integrating the publication of all aspects of research on gene therapy, stem cell therapy and ancillary basic cell/molecular biology approaches, including stem cell research, molecular cloning/sequencing, and gene regulation. The journal fulfils this aim by publishing regular research/clinical articles, short communications, and method and review papers.
Gene Therapy and Regulation�welcomes submissions of papers which report original research data on gene therapy, stem/progenitor cell therapy and tissue engineering, gene regulation, stem cell characterization/manipulation, epigenetic reprogramming, RNA/DNA transfer into mammalian cells and subsequent long term/transient gene expression, alteration or inactivation. Papers from both basic research (molecular cloning/sequencing, gene regulation/networks, design and development of vectors, delivery systems, biological and therapeutic effects, stem cell biology/engineering, cellular and animal models) and from gene/cell therapy clinical trials or investigations will be considered.
World Scientific Publishing�is a publisher of scientific, technical, and medical (STM) books and journals. The company was founded in 1981 and now employs more than 200 staff at its headquarters in�Singapore, with offices worldwide in�New Jersey,California,�London,�New Delhi,�Tianjin,�Sydney,�Hong Kong,�Taipei,�Chennai,�Beijing, and�Shanghai.